Alaunos Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRT and other ETFs, options, and stocks.About TCRT
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy.
CEOHolger Weis
CEOHolger Weis
Employees1
Employees1
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2003
Founded2003
Employees1
Employees1
TCRT Key Statistics
Market cap6.83M
Market cap6.83M
Price-Earnings ratio-1.33
Price-Earnings ratio-1.33
Dividend yield—
Dividend yield—
Average volume66.53K
Average volume66.53K
High today$4.06
High today$4.06
Low today$3.35
Low today$3.35
Open price$3.99
Open price$3.99
Volume88.34K
Volume88.34K
52 Week high$6.40
52 Week high$6.40
52 Week low$1.31
52 Week low$1.31
People also own
Based on the portfolios of people who own TCRT. This list is generated using Robinhood data, and it’s not a recommendation.